Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To Less Than 15 Years Old Who Are At High Risk For Systemic Fungal Infection

NCT01383993 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Aspergillosis, Aspergilloma

Interventions

DRUG: Voriconazole
DRUG: Voriconazole

Sponsor

Pfizer